JP2016113386A - Whitening agent and whitening cosmetic - Google Patents
Whitening agent and whitening cosmetic Download PDFInfo
- Publication number
- JP2016113386A JP2016113386A JP2014251733A JP2014251733A JP2016113386A JP 2016113386 A JP2016113386 A JP 2016113386A JP 2014251733 A JP2014251733 A JP 2014251733A JP 2014251733 A JP2014251733 A JP 2014251733A JP 2016113386 A JP2016113386 A JP 2016113386A
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- grape
- inhibitory activity
- fermented product
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 32
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 172
- 239000004310 lactic acid Substances 0.000 claims abstract description 86
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 86
- 241000219095 Vitis Species 0.000 claims abstract description 56
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 46
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 31
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 31
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 31
- 240000001929 Lactobacillus brevis Species 0.000 claims abstract description 29
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims abstract description 29
- 241000894006 Bacteria Species 0.000 claims abstract description 27
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 27
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 27
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 52
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 52
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 52
- 230000008099 melanin synthesis Effects 0.000 claims description 22
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 16
- 239000000463 material Substances 0.000 abstract description 8
- 235000009392 Vitis Nutrition 0.000 abstract 4
- 239000000047 product Substances 0.000 description 57
- 238000000855 fermentation Methods 0.000 description 30
- 230000004151 fermentation Effects 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 241000219094 Vitaceae Species 0.000 description 14
- 235000021021 grapes Nutrition 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000008188 pellet Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000194017 Streptococcus Species 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241000194033 Enterococcus Species 0.000 description 5
- 206010014970 Ephelides Diseases 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 5
- 206010042496 Sunburn Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 241000194032 Enterococcus faecalis Species 0.000 description 4
- 244000057717 Streptococcus lactis Species 0.000 description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 description 4
- 241001593968 Vitis palmata Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 229940032049 enterococcus faecalis Drugs 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 208000001382 Experimental Melanoma Diseases 0.000 description 3
- 244000199866 Lactobacillus casei Species 0.000 description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 description 3
- 241000186866 Lactobacillus thermophilus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 229940017800 lactobacillus casei Drugs 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000005456 alcohol based solvent Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000282985 Cervus Species 0.000 description 1
- 241000252206 Cypriniformes Species 0.000 description 1
- 241000520130 Enterococcus durans Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- 244000172809 Leuconostoc cremoris Species 0.000 description 1
- 235000017632 Leuconostoc cremoris Nutrition 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000135194 Pione Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、日焼けの予防、回復や、シミ、ソバカス等色素沈着を抑えるために有用な美白剤及び美白用化粧料に関する。 The present invention relates to a whitening agent and a whitening cosmetic useful for preventing and recovering sunburn and suppressing pigmentation such as spots and freckles.
日焼けの予防、回復や、シミ、ソバカス等色素沈着を抑えることは美容の重要な要素であり、肌の色素沈着の原因となるメラニンの生成を抑える技術への関心は高い。また、メラニン生成には、色素細胞のチロシナーゼが関与しているので、そのチロシナーゼの活性を阻害する技術への関心も高い。そして、副作用がなく、日常的に手軽かつ安全に利用することができ、なおかつ効果に優れた有効成分の開発が望まれている。 Prevention and recovery of sunburn and suppression of pigmentation such as spots and freckles are important elements of beauty, and there is a great interest in technology for suppressing the production of melanin that causes pigmentation of the skin. In addition, since tyrosinase of pigment cells is involved in melanin production, there is a great interest in a technology that inhibits the activity of tyrosinase. There is a demand for the development of an active ingredient that has no side effects, can be used easily and safely on a daily basis, and has excellent effects.
このような問題に対して、例えば下記特許文献1には、ブドウ果皮及び種子の乳酸菌発酵物にはチロシナーゼ阻害活性やメラニン生成抑制活性があり、皮膚の美白に有用であることが記載されている。 For such a problem, for example, the following Patent Document 1 describes that a fermented product of grape skin and seed has tyrosinase inhibitory activity and melanin production inhibitory activity, and is useful for skin whitening. .
しかしながら、上記特許文献1のブドウ果皮及び種子の乳酸菌発酵物は、単一の乳酸菌を用いた発酵物であり、そのチロシナーゼ阻害活性やメラニン生成抑制活性は、十分ではなかった。 However, the grape skin and seed lactic acid bacteria fermented product of Patent Document 1 is a fermented product using a single lactic acid bacterium, and its tyrosinase inhibitory activity and melanin production inhibitory activity were not sufficient.
本発明の目的は、日常的に手軽かつ安全に摂取でき、チロシナーゼ阻害活性やメラニン生成抑制活性に優れた美白剤及び美白用化粧料を提供することにある。 An object of the present invention is to provide a whitening agent and a whitening cosmetic that can be easily and safely ingested on a daily basis and are excellent in tyrosinase inhibitory activity and melanin production inhibitory activity.
本発明者は、種々の検討の結果、ブドウの種子及び果皮をラクトバチルス・プランタルムとラクトバチルス・ブレビスとを併用して乳酸発酵することで、それぞれ単独で乳酸発酵したよりも優れたチロシナーゼ阻害活性及びメラニン生成抑制活性が奏されることを見出し、本発明を完成するに至った。 As a result of various studies, the present inventor has conducted lactic acid fermentation of grape seeds and fruit skins in combination with Lactobacillus plantarum and Lactobacillus brevis, each having superior tyrosinase inhibitory activity than lactic acid fermentation alone. And it discovered that melanin production inhibitory activity was show | played and came to complete this invention.
すなわち、本発明は、以下の構成を有する美白剤及び美白用化粧料を提供する。
[1]ブドウの種子及び果皮をラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌で発酵して得られるブドウの乳酸発酵物及び/又はその抽出物を有効成分として含有することを特徴とする美白剤。
[2]前記ブドウの乳酸発酵物及び/又はその抽出物はチロシナーゼ阻害活性を有するものである、前記[1]に記載の美白剤。
[3]前記ブドウの乳酸発酵物及び/又はその抽出物はメラニン生成抑制活性を有するものである、前記[1]又は[2]に記載の美白剤。
[4]ブドウの種子及び果皮をラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌で発酵して得られるブドウの乳酸発酵物及び/又はその抽出物を有効成分として含有することを特徴とする美白用化粧料。
[5]前記ブドウの乳酸発酵物及び/又はその抽出物はチロシナーゼ阻害活性を有するものである、前記[4]に記載の美白用化粧料。
[6]前記ブドウの乳酸発酵物及び/又はその抽出物はメラニン生成抑制活性を有するものである、前記[4]又は[5]に記載の美白用化粧料。
That is, this invention provides the whitening agent and cosmetics for whitening which have the following structures.
[1] A lactic acid fermentation product obtained by fermenting grape seeds and skins with a lactic acid bacterium containing at least Lactobacillus plantarum and Lactobacillus brevis and / or an extract thereof as an active ingredient Whitening agent.
[2] The whitening agent according to [1], wherein the lactic acid fermented product of grape and / or the extract thereof has tyrosinase inhibitory activity.
[3] The whitening agent according to [1] or [2], wherein the lactic acid fermented product of grape and / or an extract thereof has melanin production inhibitory activity.
[4] A lactic acid fermentation product obtained by fermenting grape seeds and pericarp with lactic acid bacteria containing at least Lactobacillus plantarum and Lactobacillus brevis and / or an extract thereof as an active ingredient Whitening cosmetics.
[5] The whitening cosmetic according to [4], wherein the lactic acid fermented product of grape and / or the extract thereof has tyrosinase inhibitory activity.
[6] The whitening cosmetic according to [4] or [5], wherein the lactic acid fermented product of grape and / or an extract thereof has a melanin production inhibitory activity.
本発明の美白剤及び美白用化粧料は、ブドウの種子及び果皮をラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌で発酵して得られるブドウの乳酸発酵物及び/又はその抽出物を有効成分として含有するので、チロシナーゼ阻害活性やメラニン生成抑制活性に優れている。また、有効成分が天然素材由来であることから、安全性が高く、日常的に手軽かつ安全に摂取でき、それにより日焼けを予防及び/又は回復したり、シミ、ソバカス等色素沈着を抑えたりすることができる。 The whitening agent and whitening cosmetic composition of the present invention comprises a grape lactic acid fermented product obtained by fermenting grape seeds and skins with a lactic acid bacterium containing at least Lactobacillus plantarum and Lactobacillus brevis and / or an extract thereof. Since it contains as an active ingredient, it is excellent in tyrosinase inhibitory activity and melanin production inhibitory activity. In addition, since the active ingredient is derived from natural materials, it is highly safe and can be taken easily and safely on a daily basis, thereby preventing and / or recovering from sunburn and suppressing pigmentation such as spots and freckles. be able to.
本発明の美白剤及び美白用化粧料は、ブドウの乳酸発酵物及び/又はその抽出物を有効成分として含有してなるものである。 The whitening agent and whitening cosmetic composition of the present invention comprises a lactic acid fermented product of grape and / or an extract thereof as an active ingredient.
本発明において、原料となるブドウとしては、特に限定はなく、白系ブドウ、赤系ブドウ等のいずれでもよい。白系ブドウとしては、シャルドネ種、リースリング種、マスカット種などが挙げられる。赤系ブドウとしては、甲州種、巨峰種、ピオーネ種、カベルネ・フラン種、カベルネ・ソービニヨン種、メルロ種、ピノ・ノアール種、ピノ・ムニエ種、マスカット・ベリーA種、シラー種、ガメイ種、グルナッシュ種、ムールヴェードル種、サンソー種、グロロー種などが挙げられる。なかでも、赤系ブドウの果皮には、アントシアニンやフラボノイドなどが比較的多量に含まれているので、赤系ブドウが好ましく用いられる。原料ブドウの使用部位は、ポリフェノール類の含有量が高く、安価な原料素材でもあることから、種子及び果皮を用いる。 In the present invention, the grape as a raw material is not particularly limited, and may be white grape, red grape or the like. Examples of white grapes include Chardonnay, Riesling, and Muscat. As red grapes, Koshu, Kyoho, Pione, Cabernet Franc, Cabernet Sauvignon, Merlot, Pinot Noir, Pinot Meunier, Muscat Berry A, Schiller, Gamay, Examples include Grenache, Mourvedre, Sunsaw and Gloro. Among them, red grapes are preferably used because the skin of red grapes contains a relatively large amount of anthocyanins and flavonoids. The use site of the raw grapes is high in the content of polyphenols and is also an inexpensive raw material, so seeds and skins are used.
本発明において、原料ブドウの乳酸発酵に用いる乳酸菌は、ラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌である。ラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌で発酵することにより、原料ブドウに含まれるポリフェノール類や他の成分の量が増加したり、それら成分の体内への吸収性が高まったりして、チロシナーゼ阻害活性やメラニン生成抑制活性が向上する。また、ブドウ由来成分と、ラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌とが相乗的に作用して、チロシナーゼ阻害活性やメラニン生成抑制活性がより一層向上する。更にまた、渋み、苦味、青臭さが低減され、風味が向上する。その結果、日焼けの予防、回復や、シミ、ソバカス等色素沈着を抑える美白剤及び美白用化粧料の有効成分として、好適に用いられる。 In the present invention, a lactic acid bacterium used for lactic acid fermentation of a raw grape is a lactic acid bacterium containing at least Lactobacillus plantarum and Lactobacillus brevis. Fermentation with lactic acid bacteria containing at least Lactobacillus plantarum and Lactobacillus brevis may increase the amount of polyphenols and other components contained in the raw grapes, and increase the absorption of these components into the body. Thus, tyrosinase inhibitory activity and melanin production inhibitory activity are improved. In addition, the grape-derived component, lactic acid bacteria containing at least Lactobacillus plantarum and Lactobacillus brevis act synergistically to further improve tyrosinase inhibitory activity and melanin production inhibitory activity. Furthermore, astringency, bitterness and blue odor are reduced, and flavor is improved. As a result, it is suitably used as an active ingredient in whitening agents and whitening cosmetics that prevent and recover from sunburn and suppress pigmentation such as spots and freckles.
乳酸菌としては、ラクトバチルス・プランタルムとラクトバチルス・ブレビスの生育を妨げない範囲であれば、他の乳酸菌を添加してもよく、例えば、食品としても利用可能で安全な、エンテロコッカス・フェカリス、エンテロコッカス・フェシウム、エンテロコッカス・アビウム、エンテロコッカス・デュランス、エンテロコッカス・マラドラートス、エンテロコッカス・カセリフラブス、エンテロコッカス・ガリナール、ロイコノストック・クレモリス、ロイコノストック・シトロボラム、ロイコノストック・メゼンテロイデス、ペディオコッカス・セルビシェ、ペディオコッカス・ハロフィルス、ストレプトコッカス・アセトイニカス、ストレプトコッカス・エビウム、ストレプトコッカス・クレモリス、ストレプトコッカス・サーモフィルス、ストレプトコッカス・サングィウス、ストレプトコッカス・ソイエ、ストレプトコッカス・デュランス、ストレプトコッカス・パラシトロボルス、ストレプトコッカス・ラクチス等の乳酸球菌、ラクトバチルス・サリバリウス、ラクトバチルス・カゼイ、ラクトバチルス・アシドフィルス、ラクトバチルス・ヘルベティクス等の乳酸桿菌、ビフィドバクテリウム・ビフィダム、ビフィドバクテリウム・ロングム、ビフィドバクテリウム・ブレーベ等のビフィズス菌等が挙げられる。 As the lactic acid bacteria, other lactic acid bacteria may be added as long as they do not interfere with the growth of Lactobacillus plantarum and Lactobacillus brevis.For example, enterococcus faecalis, enterococcus Fesium, Enterococcus abium, Enterococcus durans, Enterococcus maladolats, Enterococcus caselliflavus, Enterococcus galinar, Leuconostoc cremoris, Leuconostok citrobolum, Leuconostok mezenteroides, Pediococcus cervus Halophilus, Streptococcus acetinicus, Streptococcus ebium, Streptococcus cremoris, Streptococcus thermo Streptococcus sangius, Streptococcus soye, Streptococcus dulans, Streptococcus paracitrobolus, Streptococcus lactis, etc. And Bifidobacterium such as Bifidobacterium bifidum, Bifidobacterium longum and Bifidobacterium breve.
ブドウの乳酸発酵物の抽出に用いる溶媒としては、特に限定は無い。水、メタノールやエタノール等のアルコール系溶媒等が挙げられる。好ましくは、安全性や抽出効率が高いという理由から、エタノールや含水エタノールが適している。 There is no limitation in particular as a solvent used for extraction of the lactic acid fermented product of grape. Examples include water, alcohol solvents such as methanol and ethanol. Preferably, ethanol or hydrous ethanol is suitable because of its high safety and extraction efficiency.
本発明の有効成分であるブドウの乳酸発酵物及び/又はその抽出物は、例えば以下のようにして得ることができる。 The grape lactic acid fermented product and / or extract thereof, which is an active ingredient of the present invention, can be obtained, for example, as follows.
まず、原料ブドウを粉砕し、ブドウ粉砕物を得る。好ましくは、粒径が100μm以下となるまで粉砕する。ブドウ粉砕物の粒径が100μm以下であれば、ザラツキ感が無くなり、食感の良いものとなり、更には、乳酸菌による発酵効率も向上する。原料ブドウとしては、ブドウの種子及び果皮を含むものを用いる。その場合、種子や果皮を含むブドウの果実そのものを用いてもよく、ブドウの果実から果肉や果汁を回収して残った種子や果皮を含む残渣を用いてもよい。 First, raw grapes are pulverized to obtain a pulverized grape product. Preferably, it grind | pulverizes until a particle size will be 100 micrometers or less. When the grain size of the pulverized grape is 100 μm or less, the graininess is lost, the texture is improved, and the fermentation efficiency by lactic acid bacteria is improved. As the raw grapes, grapes containing grape seeds and pericarp are used. In that case, the fruit of the grape itself containing a seed and a fruit skin may be used, and the residue containing the seed and the fruit skin remaining after recovering the pulp and juice from the fruit of the grape may be used.
原料ブドウの粉砕方法は、湿式粉砕が好ましい。湿式粉砕は、例えば、磨砕機、カッター等を用いて行うことができる。 The method for pulverizing the raw grapes is preferably wet pulverization. The wet pulverization can be performed using, for example, a grinder, a cutter or the like.
次に、得られたブドウ粉砕物に適当量の水を加え、加熱殺菌して培地を調製する。 Next, an appropriate amount of water is added to the obtained grape pulverized product, and heat-sterilized to prepare a medium.
培地中のブドウ粉砕物の濃度は、固形分換算含有量で10〜40質量%が好ましく、25〜35質量%がより好ましい。ブドウ粉砕物の濃度が10質量%未満であると、乾燥コストがかかったり、嵩比重が小さくなったりして、製剤化に不都合が生じる傾向がある。また、ブドウ粉砕物の濃度が40質量%を超えると、粘度が上昇して攪拌し難くなり、乳酸発酵が不均一に行われる傾向があり、更には、乳酸菌の増殖に時間がかかって生産性が低下する傾向がある。 10-40 mass% is preferable at solid content conversion content, and the density | concentration of the grape ground material in a culture medium has more preferable 25-35 mass%. If the concentration of the pulverized grape is less than 10% by mass, the drying cost is increased and the bulk specific gravity is decreased, which tends to cause inconvenience in formulation. Further, when the concentration of the pulverized grape product exceeds 40% by mass, the viscosity increases and it becomes difficult to stir, and lactic acid fermentation tends to be performed unevenly. Tends to decrease.
加熱殺菌は、110〜125℃で、10〜30分間行うことが好ましく、115〜120℃で、10〜20分間行うことがより好ましい。上記条件で加熱殺菌を行うことにより、チロシナーゼ阻害活性やメラニン生成抑制活性を担う成分を破壊することなく、雑菌などの繁殖を抑制できる。 The heat sterilization is preferably performed at 110 to 125 ° C. for 10 to 30 minutes, more preferably at 115 to 120 ° C. for 10 to 20 minutes. By performing heat sterilization under the above-described conditions, propagation of miscellaneous bacteria and the like can be suppressed without destroying components responsible for tyrosinase inhibitory activity and melanin production inhibitory activity.
次に、上記のように調製したブドウ由来組成物に、乳酸菌を添加して乳酸発酵を行う。乳酸菌としては、前述したように、ラクトバチルス・プランタルムとラクトバチルス・ブレビスとを少なくとも含む乳酸菌を用いる。乳酸菌の添加量は特に限定されないが、培地1リットルに対して、両者合計の菌体数が1×109〜1×1010個となるように添加することが好ましく、ラクトバチルス・プランタルムの菌体数が5×108〜5×109個、ラクトバチルス・ブレビスの菌体数が5×108〜5×109個となるように添加することがより好ましい。 Next, lactic acid fermentation is performed by adding lactic acid bacteria to the grape-derived composition prepared as described above. As described above, lactic acid bacteria containing at least Lactobacillus plantarum and Lactobacillus brevis are used. Although the addition amount of lactic acid bacteria is not particularly limited, it is preferable to add them so that the total number of cells is 1 × 10 9 to 1 × 10 10 per liter of the medium, and the bacteria of Lactobacillus plantarum It is more preferable to add so that the number of cells is 5 × 10 8 to 5 × 10 9 and the number of Lactobacillus brevis cells is 5 × 10 8 to 5 × 10 9 .
乳酸発酵は、温度27〜37℃、pH3〜7、培養時間24〜72時間の条件で行うことが好ましく、より好ましくは、温度30〜33℃、pH4.5〜6、培養時間40〜50時間の条件で行う。 Lactic acid fermentation is preferably performed under conditions of a temperature of 27 to 37 ° C., a pH of 3 to 7, and a culture time of 24 to 72 hours, and more preferably a temperature of 30 to 33 ° C., a pH of 4.5 to 6 and a culture time of 40 to 50 hours. Perform under the conditions of
このようにして乳酸発酵して得られるブドウの乳酸発酵物は、乳酸発酵前の状態に比べてポリフェノール含量が増加し、かつ、ポリフェノール類の体内への吸収性が高められている。この理由としては、乳酸発酵により、ポリフェノール類の配糖体が切断されたり、有機酸が結合したものによると考えられる。また、この乳酸発酵物には、乳酸発酵物の固形分100mg中に、乳酸菌が1×108〜1×1010個含まれていることが好ましい。ラクトバチルス・プランタルム、ラクトバチルス・ブレビスは、同発酵物の固形分100mg中に、ラクトバチルス・プランタルムの菌体数が5×108〜5×109個、ラクトバチルス・ブレビスの菌体数が5×108〜5×109個含まれていることが好ましい。 Thus, the lactic acid fermented product of grape obtained by lactic acid fermentation has an increased polyphenol content as compared with the state before lactic acid fermentation, and the absorbability of polyphenols into the body is enhanced. The reason for this is thought to be that glycosides of polyphenols are cleaved or bound with organic acids by lactic acid fermentation. Further, the lactic acid fermentation product, in solid 100mg of lactic acid fermentation product, it is preferable that lactic acid bacteria are contained 10 10 1 × 10 8 ~1 ×. Lactobacillus plantarum and Lactobacillus brevis have 5 × 10 8 to 5 × 10 9 cells of Lactobacillus plantarum and 100 cells of Lactobacillus brevis in a solid content of 100 mg of the same fermented product. It is preferable that 5 * 10 < 8 > -5 * 10 < 9 > pieces are contained.
そして、上記乳酸発酵物を、60〜80℃で、5〜10分間加熱殺菌し、必要に応じて、ガラクトオリゴ糖、ショ糖などの糖類や、果汁などを加えることで、液状の乳酸発酵物が得られる。 And the said lactic acid fermented product is heat-sterilized at 60-80 degreeC for 5 to 10 minutes, and saccharides, such as galactooligosaccharide and sucrose, fruit juice, etc. are added as needed, and a liquid lactic acid fermented product becomes. can get.
また、加熱殺菌後の上記乳酸発酵物を乾燥、粉末化することで、粉末状の乳酸発酵物が得られる。加熱殺菌後の乳酸発酵物の乾燥方法としては、例えば熱風乾燥、噴霧乾燥、ドラム乾燥、真空乾燥などが挙げられるが、チロシナーゼ阻害活性やメラニン生成抑制活性を担う成分の破壊が少なく、優れた生理活性を維持し易いという理由から凍結乾燥が好ましい。凍結乾燥は、例えば、発酵物を−60〜−40℃で1〜3時間凍結し、圧力0.1mbr以下、時間24〜48時間、温度20〜30℃の条件で行うことが好ましい。 Moreover, a powdery lactic acid fermented product is obtained by drying and pulverizing the said lactic acid fermented product after heat sterilization. Examples of the drying method of the lactic acid fermented product after heat sterilization include hot air drying, spray drying, drum drying, vacuum drying, etc., but there is little destruction of components responsible for tyrosinase inhibitory activity and melanin production inhibitory activity, and excellent physiological Lyophilization is preferred because it is easy to maintain activity. The freeze-drying is preferably performed, for example, by freezing the fermented product at −60 to −40 ° C. for 1 to 3 hours and under a pressure of 0.1 mbr or less, a time of 24 to 48 hours, and a temperature of 20 to 30 ° C.
また、上記乳酸発酵物から、抽出溶媒を用いて抽出することで、乳酸発酵物の抽出物が得られる。抽出溶媒としては、前述したように、特に限定は無い。水、メタノールやエタノール等のアルコール系溶媒等が挙げられる。好ましくは、安全性や抽出効率が高いという理由から、エタノールや含水エタノールが適している。抽出方法としては、上記乳酸発酵物を抽出溶媒に懸濁させ、20〜40℃で、2〜48時間振とうする方法等が挙げられる。抽出物は、必要なら固形物を濾過除去したうえで用いてもよく、更に、濃縮あるいは乾燥粉末化したものを用いてもよい。 Moreover, the extract of a lactic acid fermented product is obtained by extracting from the said lactic acid fermented product using an extraction solvent. As described above, the extraction solvent is not particularly limited. Examples include water, alcohol solvents such as methanol and ethanol. Preferably, ethanol or hydrous ethanol is suitable because of its high safety and extraction efficiency. Examples of the extraction method include a method in which the lactic acid fermented product is suspended in an extraction solvent and shaken at 20 to 40 ° C. for 2 to 48 hours. If necessary, the extract may be used after removing solids by filtration, and may further be concentrated or dried powder.
本発明の美白剤は、上記乳酸発酵物及び/又はその抽出物を含有してなるものであり、チロシナーゼ阻害活性やメラニン生成抑制活性の点において優れた効果を示し、これを摂取することにより、日焼けを予防及び/又は回復したり、シミ、ソバカス等色素沈着を抑えたりすることができる。投与形態は、特に制限はないが、経口摂取、あるいは皮膚塗布によることが好ましい。そして、医薬品、化粧料、食品等の各種分野で用いられ、その医薬品の有効成分、化粧料や食品の原料等として使用することができる。 The whitening agent of the present invention contains the lactic acid fermented product and / or the extract thereof, and exhibits an excellent effect in terms of tyrosinase inhibitory activity and melanin production inhibitory activity. Sunburn can be prevented and / or recovered, and pigmentation such as spots and freckles can be suppressed. The dosage form is not particularly limited, but is preferably taken orally or by skin application. And it is used in various fields, such as a pharmaceutical, cosmetics, and a foodstuff, and can be used as an active ingredient of the pharmaceutical, a raw material of cosmetics, a foodstuff, etc.
例えば、医薬品とする場合には、薬学的に許容される基材や担体と共に製剤化し、医薬組成物として提供することができる。医薬組成物の形態としては、丸剤、散剤、錠剤、顆粒剤、カプセル剤、シロップ剤、液剤、ゼリー剤、トローチ剤等の形態が例示できる。 For example, in the case of a pharmaceutical product, it can be formulated with a pharmaceutically acceptable substrate or carrier and provided as a pharmaceutical composition. Examples of the form of the pharmaceutical composition include pills, powders, tablets, granules, capsules, syrups, liquids, jellies, lozenges and the like.
また、化粧料とする場合には、化粧料に許容される基材や担体と共に製剤化し、化粧料の原料として配合することができる。化粧料の形態としては、クリーム剤、ジェル、軟膏剤、化粧液剤、噴霧液剤、泡状製剤、パック、フェイスマスク等の形態が例示できる。 Moreover, when it is set as cosmetics, it can formulate with the base material and carrier accept | permitted in cosmetics, and can mix | blend as a raw material of cosmetics. Examples of cosmetic forms include creams, gels, ointments, cosmetic solutions, spray solutions, foam preparations, packs, face masks and the like.
また、食品とする場合には、一般の食品の他、特に、機能性表示食品、栄養補助食品、保健用食品等に配合して用いることができる。 Moreover, when it is set as a foodstuff, it can be mix | blended and used for a functional display food, a nutritional supplement, a health food etc. especially in addition to a general food.
本発明の美白剤の有効摂取量は、経口的に摂取する場合、成人一日当り、上記有効成分の固形分換算で100mg〜3gが好ましい。また、皮膚に塗布する場合、成人一日当り、適用面積1cm2当たり、上記有効成分の固形分換算で50mg〜250gが好ましい。 The effective intake of the whitening agent of the present invention is preferably 100 mg to 3 g in terms of solid content of the above active ingredient per day for an adult when taken orally. Also, when applied to the skin, adult per day, applied area 1 cm 2 per, 50Mg~250g preferably in terms of solid content of the active ingredient.
以下実施例を挙げて本発明を具体的に説明するが、これらの実施例は本発明の範囲を限定するものではない。 EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but these examples do not limit the scope of the present invention.
(実施例1)
甲州種のブドウの種子及び果皮1kgに1Lの水を加え、微粒磨砕機を用いて湿式粉砕し、粒径100μm以下のブドウ粉砕物を得た。このブドウ粉砕物2kgに水1Lを加え、pHを6とし、120℃で20分間加熱殺菌した。この加熱殺菌処理物に、ラクトバチルス・プランタルムの前培養液5mL(菌体数5×109個)と、ラクトバチルス・ブレビスの前培養液5mL(菌体数5×109個)とを加え、温度を33±1℃に維持し、48時間発酵させた。
Example 1
1 L of water was added to 1 kg of Koshu grape seeds and pericarp, and wet pulverized using a fine grinder to obtain a crushed grape having a particle size of 100 μm or less. 1 L of water was added to 2 kg of the pulverized grapes to adjust the pH to 6, and sterilized by heating at 120 ° C for 20 minutes. To this heat-sterilized product, 5 mL of Lactobacillus plantarum preculture solution (5 × 10 9 cells) and 5 mL of Lactobacillus brevis preculture solution (5 × 10 9 cells) are added. The temperature was maintained at 33 ± 1 ° C. and fermented for 48 hours.
発酵終了後、70℃で10分間加熱殺菌し、−40℃に凍結させた後、圧力0.1mbr以下、24時間、30℃の条件で凍結乾燥処理して、粉末状のブドウの乳酸発酵物を250g得た。このブドウの乳酸発酵物100mg中には、ラクトバチルス・プランタルムの死菌体が5×108個、ラクトバチルス・ブレビスの死菌体が5×108個含まれていた。また、総ポリフェノール含有量は、没食子酸相当量で23mgであり、DPPHラジカル消去活性は、Trolox相当量で242μmolであった。 After completion of fermentation, heat sterilized at 70 ° C. for 10 minutes, frozen at −40 ° C., freeze-dried under conditions of pressure 0.1 mbr or less, 24 hours, 30 ° C., and powdered lactic acid fermentation product of grape Of 250 g was obtained. The grapes during lactic acid fermentation product 100mg of killed microbial cells of Lactobacillus plantarum is 5 × 10 8 cells, dead cells of Lactobacillus brevis was included 5 × 10 8 pieces. The total polyphenol content was 23 mg in terms of gallic acid, and the DPPH radical scavenging activity was 242 μmol in terms of Trolox.
(比較例1)
乳酸菌として、ラクトバチルス・ブレビスを用いずに、ラクトバチルス・プランタルムを菌体数10×109個でブドウ粉砕物に加えて用いた以外は、実施例1と同様にして、ブドウの乳酸発酵物を得た。
(Comparative Example 1)
As a lactic acid bacterium, a lactic acid fermented product of grapes was used in the same manner as in Example 1 except that Lactobacillus plantarum was used in addition to Lactobacillus plantarum with 10 × 10 9 bacterial cells and added to the pulverized grape. Got.
(比較例2)
乳酸菌として、ラクトバチルス・プランタルムを用いずに、ラクトバチルス・ブレビスを菌体数10×109個でブドウ粉砕物に加えて用いた以外は、実施例1と同様にして、ブドウの乳酸発酵物を得た。
(Comparative Example 2)
A lactic acid fermentation product of grapes in the same manner as in Example 1 except that Lactobacillus brevis was used as a lactic acid bacterium without adding Lactobacillus plantarum to the pulverized product of 10 × 10 9 cells. Got.
(比較例3)
乳酸菌として、ラクトバチルス・プランタルムとラクトバチルス・ブレビスに代えて、ラクトバチルス・カゼイとストレプトコッカス・ラクティスを、それぞれ菌体数5×109個でブドウ粉砕物に加えて用いた以外は、実施例1と同様にして、ブドウの乳酸発酵物を得た。
(Comparative Example 3)
Example 1 except that, instead of Lactobacillus plantarum and Lactobacillus brevis, Lactobacillus casei and Streptococcus lactis were used as lactic acid bacteria in addition to 5 × 10 9 cells in addition to the crushed grapes, respectively. In the same manner, a lactic acid fermentation product of grape was obtained.
(比較例4)
乳酸菌として、ラクトバチルス・プランタルムとラクトバチルス・ブレビスに代えて、ラクトバチルス・サーモフィルスとエンテロコッカス・フェカリスを、それぞれ菌体数5×109個でブドウ粉砕物に加えて用いた以外は、実施例1と同様にして、ブドウの乳酸発酵物を得た。
(Comparative Example 4)
Example except that, instead of Lactobacillus plantarum and Lactobacillus brevis, Lactobacillus thermophilus and Enterococcus faecalis were used as lactic acid bacteria in addition to 5 × 10 9 cells in addition to the pulverized grapes, respectively. In the same manner as in No. 1, a lactic acid fermentation product of grape was obtained.
<試験例1>(チロシナーゼ阻害活性)
実施例1、比較例1〜4のブドウの乳酸発酵物について、チロシナーゼ阻害活性を測定した。阻害活性は、ブドウの乳酸発酵物の代わりに水を添加したときのチロシナーゼ活性と比較することにより求めた。また、参考例として、乳酸発酵物の調製に用いたブドウ粉砕物の加熱殺菌処理物を、そのまま凍結乾燥した非発酵物についても、チロシナーゼ阻害活性を測定した。以下に被検試料をまとめて示す。また、チロシナーゼ阻害活性の測定方法を示す。
<Test Example 1> (Tyrosinase inhibitory activity)
Tyrosinase inhibitory activity was measured for the lactic acid fermented products of grapes of Example 1 and Comparative Examples 1 to 4. The inhibitory activity was determined by comparing with the tyrosinase activity when water was added instead of the lactic acid fermented product of grape. In addition, as a reference example, tyrosinase inhibitory activity was also measured for a non-fermented product obtained by freeze-drying the heat-sterilized processed product of the pulverized grape used in the preparation of the lactic acid fermented product. The test samples are summarized below. Moreover, the measuring method of tyrosinase inhibitory activity is shown.
[被検試料]
A:対照(水)
B:参考例(ブドウの種子及び果皮の非発酵物)
C:実施例1(Lactobacillus plantarum + Lactobacillus brevis)
D:比較例1(Lactobacillus plantarum)
E:比較例2(Lactobacillus brevis)
F:比較例3(Lactobacillus casei + Streptococcus lactis)
G:比較例4(Lactobacillus thermophilus + Enterococcus faecalis)
[Test sample]
A: Control (water)
B: Reference example (non-fermented product of grape seeds and pericarp)
C: Example 1 (Lactobacillus plantarum + Lactobacillus brevis)
D: Comparative example 1 (Lactobacillus plantarum)
E: Comparative Example 2 (Lactobacillus brevis)
F: Comparative Example 3 (Lactobacillus casei + Streptococcus lactis)
G: Comparative example 4 (Lactobacillus thermophilus + Enterococcus faecalis)
[測定方法]
・試料の調製
発酵物または非発酵物100mgを80%メタノール10mLに懸濁し、3時間振盪しながら抽出した。遠心分離して得られた上清液からメタノールを除去し、再度10mLに調製して、試料とした。
[Measuring method]
-Preparation of sample 100 mg of fermented or non-fermented product was suspended in 10 mL of 80% methanol and extracted with shaking for 3 hours. Methanol was removed from the supernatant obtained by centrifugation, and the mixture was prepared again to 10 mL to prepare a sample.
・分析方法
上記試料0.3mLを取り、これにクエン酸緩衝液(20mM、pH6.8)3mLを加え、さらにチロシナーゼ溶液(マッシュルーム由来チロシナーゼを400U/mLになるようにクエン酸緩衝液で調製)0.3mLを加えて37℃、10分間インキュベートした。その後、チロシン溶液(1.11μmol/mL)3mLを加えて37℃、20分間反応させた。490nmの吸光度を測定し、上記試料0.3mLの代わりに水0.3mLを用いた場合のチロシナーゼ活性を100としたときの相対活性を求めた。
Analytical method Take 0.3 mL of the above sample, add 3 mL of citrate buffer (20 mM, pH 6.8) to this, and further tyrosinase solution (prepared with citrate buffer so that mushroom-derived tyrosinase is 400 U / mL) 0.3 mL was added and incubated at 37 ° C. for 10 minutes. Then, 3 mL of tyrosine solution (1.11 μmol / mL) was added and reacted at 37 ° C. for 20 minutes. Absorbance at 490 nm was measured, and the relative activity was determined when the tyrosinase activity was set to 100 when 0.3 mL of water was used instead of 0.3 mL of the sample.
結果を図1に示す。 The results are shown in FIG.
図1に示されるように、非発酵物を用いた参考例では、チロシナーゼ活性は、対照の60%程度であった。ラクトバチルス・プランタルム、又はラクトバチルス・ブレビスを単独で用いて乳酸発酵した比較例1、2では、その乳酸発酵により阻害活性が向上し、ラクトバチルス・プランタルムとラクトバチルス・ブレビスを併用して用いて乳酸発酵した実施例1では、阻害活性が更により一層向上した。それに対して、乳酸菌として、ララクトバチルス・カゼイとストレプトコッカス・ラクティスを併用して用いて乳酸発酵した比較例3や、ラクトバチルス・サーモフィルスとエンテロコッカス・フェカリスを併用して用いて乳酸発酵した比較例4では、非発酵物を用いた参考例と同程度の阻害活性しか得られなかった。 As shown in FIG. 1, in the reference example using the non-fermented product, the tyrosinase activity was about 60% of the control. In Comparative Examples 1 and 2 in which lactic acid fermentation was performed using Lactobacillus plantarum or Lactobacillus brevis alone, the inhibitory activity was improved by the lactic acid fermentation, and Lactobacillus plantarum and Lactobacillus brevis were used in combination. In Example 1 subjected to lactic acid fermentation, the inhibitory activity was further improved. On the other hand, as a lactic acid bacterium, Lactobacillus casei and Streptococcus lactis were used in combination with Comparative Example 3, and Lactobacillus thermophilus and Enterococcus faecalis were used in combination with lactic acid fermentation. In No. 4, only inhibitory activity comparable to the reference example using a non-fermented material was obtained.
<試験例2>(メラニン生成抑制活性)
実施例1、比較例1〜2のブドウの乳酸発酵物について、B16メラノーマ細胞のメラニン生成を抑制する活性を試験した。抑制活性は、ブドウの乳酸発酵物の代わりに水を添加したときのメラニン生成量と比較することにより求めた。また、参考例として、乳酸発酵物の調製に用いたブドウ粉砕物の加熱殺菌処理物を、そのまま凍結乾燥した非発酵物についても、メラニン生成抑制活性を試験した。以下に被検試料をまとめて示す。また、メラニン生成抑制活性の試験方法を示す。
<Test Example 2> (Melanin production inhibitory activity)
About the lactic acid fermented product of the grape of Example 1 and Comparative Examples 1-2, the activity which suppresses the melanin production | generation of B16 melanoma cell was tested. The inhibitory activity was determined by comparing with the amount of melanin produced when water was added instead of the lactic acid fermented product of grape. Moreover, as a reference example, the melanin production inhibitory activity was tested also about the non-fermented material which freeze-dried the heat-sterilized processed product of the grape ground material used for preparation of a lactic acid fermented product as it is. The test samples are summarized below. Moreover, the test method of melanin production inhibitory activity is shown.
[被検試料]
A:対照(水)
B:参考例(ブドウの種子及び果皮の非発酵物)
C:実施例1(Lactobacillus plantarum + Lactobacillus brevis)
D:比較例1(Lactobacillus plantarum)
E:比較例2(Lactobacillus brevis)
[Test sample]
A: Control (water)
B: Reference example (non-fermented product of grape seeds and pericarp)
C: Example 1 (Lactobacillus plantarum + Lactobacillus brevis)
D: Comparative example 1 (Lactobacillus plantarum)
E: Comparative Example 2 (Lactobacillus brevis)
[試験方法]
・試料の調製
発酵物および非発酵物100mgを蒸留水10mLに懸濁し、3時間振盪しながら抽出した。遠心分離して得られた上清液を凍結乾燥して、試料とした。
[Test method]
-Preparation of sample 100 mg of fermented products and non-fermented products were suspended in 10 mL of distilled water and extracted with shaking for 3 hours. The supernatant obtained by centrifugation was freeze-dried to prepare a sample.
・B16メラノーマ細胞の培養
B16メラノーマ細胞は、5%牛胎児血清(FBS)含有Doulbecco’s modified Eagle’s Medium(5%FBS含有DMEM)を用いて1.0×104cells/wellの濃度に調製し、6well plateに播種して、37度、5%CO2気相下で培養を開始した。24時間培養後、上記試料を5%FBS含有DMEMに0.05%添加した培地を用いて培地交換した。72時間毎に同様の培地交換を行いながら、6日間培養した。なお、対照には、上記試料の代わりに超純水を用いた。
-Culture of B16 melanoma cells B16 melanoma cells were prepared to a concentration of 1.0 × 10 4 cells / well using Doulbecco's modified Eagle's Medium (5% FBS-containing DMEM) containing 5% fetal bovine serum (FBS). The cells were seeded on a plate and cultured at 37 ° C. in a 5% CO 2 gas phase. After culturing for 24 hours, the medium was changed using a medium in which 0.05% of the sample was added to DMEM containing 5% FBS. The cells were cultured for 6 days while changing the medium every 72 hours. As a control, ultrapure water was used instead of the sample.
・分析方法
培養後、0.25%トリプシン溶液で細胞を剥がし、その溶液を遠心分離して細胞ペレットを作成した。1.5mLのPBS(−)緩衝液にペレットを懸濁させ、0.3mLをタンパク質測定用、1.2mLをメラニン定量用とした。
-Analysis method After culture, the cells were detached with a 0.25% trypsin solution, and the solution was centrifuged to prepare a cell pellet. The pellet was suspended in 1.5 mL of PBS (−) buffer, 0.3 mL was used for protein measurement, and 1.2 mL was used for melanin determination.
タンパク質測定は次のようにして行った。すなわち、0.3mLの細胞懸濁液を遠心分離して細胞をペレットにし、そのペレットをPBS(−)緩衝液で3回洗浄した。ペレットに0.5%Triton X−100含有PBS(−)緩衝液1mL添加し、20分間ボルテックス処理を行い、細胞タンパク溶解液を得た。得られた細胞タンパク溶解液について、常法に従い、Lowry法でタンパク量を定量した。 Protein measurement was performed as follows. That is, 0.3 mL of the cell suspension was centrifuged to pellet the cells, and the pellet was washed 3 times with PBS (−) buffer. 1 mL of PBS (-) buffer containing 0.5% Triton X-100 was added to the pellet and vortexed for 20 minutes to obtain a cell protein lysate. About the obtained cell protein solution, protein amount was quantified by the Lowry method according to a conventional method.
メラニン定量は次のようにして行った。すなわち、1.2mLの細胞懸濁液を遠心分離して細胞をペレットにし、ペレットをPBS(−)緩衝液、5%トリクロロ酢酸溶液、エタノール/ジエチルエーテル(1:3)溶液でそれぞれ3回ずつ洗浄した後、ジエチルエーテルで1回洗浄した。ペレットを1時間、50℃に加熱して十分乾燥させた後、1M水酸化ナトリウム溶液150μLを添加し、100℃、10分間加熱してメラニンを可溶化した。マイクロプレートリーダーを用いてメラニンの405nmの吸光度を測定し、タンパク量当たりの吸光度でメラニン量を比較した。 Melanin quantification was performed as follows. That is, 1.2 mL of the cell suspension was centrifuged to pellet the cells, and the pellets were each three times with PBS (−) buffer, 5% trichloroacetic acid solution, and ethanol / diethyl ether (1: 3) solution. After washing, it was washed once with diethyl ether. The pellets were heated to 50 ° C. for 1 hour and sufficiently dried, and then 150 μL of 1M sodium hydroxide solution was added and heated to 100 ° C. for 10 minutes to solubilize melanin. The absorbance at 405 nm of melanin was measured using a microplate reader, and the amount of melanin was compared with the absorbance per protein amount.
結果を図2に示す。 The results are shown in FIG.
図2に示されるように、非発酵物を用いた参考例では、メラニン生成活性は、対照の80%程度であった。ラクトバチルス・プランタルム、又はラクトバチルス・ブレビスを単独で用いて乳酸発酵した比較例1、2では、その乳酸発酵によりメラニン生成抑制活性が向上したが、ラクトバチルス・プランタルムとラクトバチルス・ブレビスを併用して用いて乳酸発酵した実施例1では、メラニン生成抑制活性が更により一層向上した。 As shown in FIG. 2, in the reference example using the non-fermented product, the melanogenesis activity was about 80% of the control. In Comparative Examples 1 and 2 in which lactic acid fermentation was performed using Lactobacillus plantarum or Lactobacillus brevis alone, the melanin production inhibitory activity was improved by the lactic acid fermentation, but Lactobacillus plantarum and Lactobacillus brevis were used in combination. In Example 1, which was used for lactic acid fermentation, the melanin production inhibitory activity was further improved.
<製造例1>
下記表1の配合にて、常法に従い、実施例1で得られたブドウの乳酸発酵物を含有する錠剤を製造した。
<Production Example 1>
Tablets containing the lactic acid fermentation product of grape obtained in Example 1 were produced according to a conventional method with the formulation shown in Table 1 below.
<製造例2>
下記表2の配合にて、常法に従い、実施例1で得られたブドウの乳酸発酵物を含有するドリンク剤を製造した。
<Production Example 2>
A drink containing the lactic acid fermented product of grape obtained in Example 1 was produced according to a conventional method with the formulation shown in Table 2 below.
<製造例3>
下記表3の配合にて、常法に従い、実施例1で得られたブドウの乳酸発酵物を含有するクリーム剤を製造した。
<Production Example 3>
A cream containing the lactic acid fermentation product of grape obtained in Example 1 was prepared according to a conventional method with the formulation shown in Table 3 below.
Claims (6)
The whitening cosmetic according to claim 4 or 5, wherein the grape lactic acid fermented product and / or an extract thereof has a melanin production inhibitory activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014251733A JP6133834B2 (en) | 2014-12-12 | 2014-12-12 | Whitening agent and whitening cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014251733A JP6133834B2 (en) | 2014-12-12 | 2014-12-12 | Whitening agent and whitening cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016113386A true JP2016113386A (en) | 2016-06-23 |
JP6133834B2 JP6133834B2 (en) | 2017-05-24 |
Family
ID=56140794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014251733A Active JP6133834B2 (en) | 2014-12-12 | 2014-12-12 | Whitening agent and whitening cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6133834B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190112879A (en) * | 2018-03-26 | 2019-10-08 | (주) 비에스티 | A Method for Producing a Natural Whitening Agent Based on a Fermented Component of a Citrus Junos Seed Embryo |
CN112481148A (en) * | 2019-08-22 | 2021-03-12 | 丰华生物科技股份有限公司 | Composition containing lactic acid bacteria fermentation product for whitening efficacy and application thereof |
CN112825990A (en) * | 2019-11-01 | 2021-05-25 | 大江生医股份有限公司 | Use of red grape fermented juice for the preparation of a composition for improving skin condition |
WO2022139125A1 (en) * | 2020-12-23 | 2022-06-30 | (주)진셀팜 | Cosmetic composition comprising fermented grape extract |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005325105A (en) * | 2004-04-15 | 2005-11-24 | Yougo Takaoka | Skin care preparation for external use |
WO2008093670A1 (en) * | 2007-02-01 | 2008-08-07 | Tk Bio-Research Laboratory Co., Ltd. | Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same |
-
2014
- 2014-12-12 JP JP2014251733A patent/JP6133834B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005325105A (en) * | 2004-04-15 | 2005-11-24 | Yougo Takaoka | Skin care preparation for external use |
WO2008093670A1 (en) * | 2007-02-01 | 2008-08-07 | Tk Bio-Research Laboratory Co., Ltd. | Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190112879A (en) * | 2018-03-26 | 2019-10-08 | (주) 비에스티 | A Method for Producing a Natural Whitening Agent Based on a Fermented Component of a Citrus Junos Seed Embryo |
KR102095802B1 (en) * | 2018-03-26 | 2020-04-02 | (주) 비에스티 | A Method for Producing a Natural Whitening Agent Based on a Fermented Component of a Citrus Junos Seed Embryo |
CN112481148A (en) * | 2019-08-22 | 2021-03-12 | 丰华生物科技股份有限公司 | Composition containing lactic acid bacteria fermentation product for whitening efficacy and application thereof |
CN112825990A (en) * | 2019-11-01 | 2021-05-25 | 大江生医股份有限公司 | Use of red grape fermented juice for the preparation of a composition for improving skin condition |
WO2022139125A1 (en) * | 2020-12-23 | 2022-06-30 | (주)진셀팜 | Cosmetic composition comprising fermented grape extract |
Also Published As
Publication number | Publication date |
---|---|
JP6133834B2 (en) | 2017-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7658391B2 (en) | Anti-pollution agent and composition for external use on skin | |
JP6714928B2 (en) | Collagenase inhibitor | |
JP6133834B2 (en) | Whitening agent and whitening cosmetic | |
KR20180061740A (en) | Composition for prevention or treatment of improvement of cognitive ability with fermented spirulina extract and method for preparing thereof | |
JP2023171681A (en) | antioxidant | |
KR101829526B1 (en) | Composition for Immune Stimulation Comprising Fermented Cervi Parvum Cornu Extract or Fractions thereof | |
KR20100015326A (en) | Melanogenesis inhibitory composition | |
CN108157959A (en) | Probiotics black garlic composition, compound probiotic black garlic powder and preparation method thereof | |
JP2008280310A (en) | Promoter for forming and metabolizing testosterone | |
KR20170106187A (en) | Antioxidant Composition | |
TWI465237B (en) | Neuroblast cell multiplication promoter and synapse extender | |
JP5921151B2 (en) | Hyaluronidase activity inhibitor | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
JP2007099625A (en) | Skin fibroblast growth promoter | |
JP5548393B2 (en) | Method for producing fermented grapes | |
JP7570718B2 (en) | Composition | |
CN115025129A (en) | Lactobacillus-containing composition and application thereof in preventing and/or improving skin aging | |
JP2004091396A (en) | Whitening agent | |
JP7382622B2 (en) | Composition | |
JP2010280602A (en) | Antiallergic composition | |
JP2021138770A (en) | Anti-allergic agent, intestinal immunopotentiator, lactic acid bacterium intestinal adhesion improver | |
JP7569581B2 (en) | Composition | |
JP6792270B2 (en) | Whitening composition | |
JP2005089385A (en) | Lipoxygenase inhibitor | |
KR102155235B1 (en) | Functional food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160801 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20161006 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20161212 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20161213 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170418 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170420 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6133834 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |